Chenodiol

Chenodiol

SCHEMBL25056

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)CC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

NR1H4

The experimentally established mechanism targets of Chenodiol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1H4 known ✓ Q96RI1 7/20 1.00
GPBAR1 Q8TDU6 14/20 1.00
ABCB11 O95342 3/20 1.00
MEN1 O00255 2/20 1.00
KMT2A Q03164 2/20 1.00
SLC10A2 Q12908 2/20 1.00
ENPP2 Q13822 2/20 1.00
CYP3A4 P08684 2/20 1.00
LMNA P02545 1/20 1.00
CYP2C19 P33261 1/20 1.00
CHRM2 P08172 1/20 1.00
ADRA2A P08913 1/20 1.00
ADRA1A P35348 1/20 1.00
TDP1 Q9NUW8 1/20 1.00
SLC10A1 Q14973 1/20 1.00
CISD1 Q9NZ45 1/20 1.00
PDE3A Q14432 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chenodiol SCHEMBL22079588 1.00 GPBAR1 (1.00) GPBAR1NR1H4ABCB11MEN1KMT2A
Chenodiol SCHEMBL24199134 1.00 GPBAR1 (1.00) GPBAR1NR1H4ABCB11MEN1KMT2A
Chenodiol SCHEMBL23517166 1.00 GPBAR1 (1.00) GPBAR1NR1H4ABCB11MEN1KMT2A
Chenodiol SCHEMBL22079179 1.00 GPBAR1 (1.00) GPBAR1NR1H4ABCB11MEN1KMT2A
Chenodiol SCHEMBL25337643 1.00 GPBAR1 (1.00) GPBAR1NR1H4ABCB11MEN1KMT2A
Chenodiol SCHEMBL24124587 1.00 GPBAR1 (1.00) GPBAR1NR1H4ABCB11MEN1KMT2A
Chenodiol SCHEMBL25397934 1.00 GPBAR1 (1.00) GPBAR1NR1H4ABCB11MEN1KMT2A
Chenodiol SCHEMBL24061005 1.00 GPBAR1 (1.00) GPBAR1NR1H4ABCB11MEN1KMT2A
Chenodiol SCHEMBL23704676 1.00 GPBAR1 (1.00) GPBAR1NR1H4ABCB11MEN1KMT2A
Chenodiol SCHEMBL25337648 1.00 GPBAR1 (1.00) GPBAR1NR1H4ABCB11MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 25707 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
CN-122074420-A Evaluation method of bile acid in relieving intestinal inflammation of east star spots 2026-05-26 CN claimed
CN-122070276-A Prodrugs of xanomeline, prodrugs of trospium chloride and methods of using the same 人类生物科学股份有限公司 2026-05-19 CN claimed
CN-122060831-A Method and device for generating ursodeoxycholic acid by continuous flow catalytic chenodeoxycholic acid 南京师范大学 2026-05-19 CN claimed
CN-122030504-A Application of silybin combined chenodeoxycholic acid in improving quality degradation of procambarus clarkia caused by zero fish meal feed 广东海洋大学 2026-05-15 CN claimed
US-20260131089-A1 DRUG DELIVERY DEVICES AND METHODS FOR ADMINISTERING SUBSTANCES TO A BODY CAVITY BY HETEROGENOUS AEROSOLIZATION FOR TREATMENT OF BINGE-EATING DISORDERS AND/OR OBESITY APTARGROUP, INC. (US) 2026-05-14 US claimed
EP-3869192-B1 METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE HUMAN METABOLOMICS INST INC (CN) 2026-05-13 EP claimed
CN-122017068-A Bile acid high-flux detection method based on ultra-high performance liquid chromatography tandem mass spectrometry and application thereof 青岛百谱生物科技有限公司 2026-05-12 CN claimed
EP-4736862-A1 COMPOSITION PROVIDING IMPROVED ORAL BIOAVAILABILITY OF DRUG AND METHOD THEREFOR Hang Zhou Sciwind Biosciences Co., Ltd. (CN) 2026-05-06 EP claimed
EP-4082552-B1 LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE UNIV TEXAS (US) 2026-05-06 EP claimed
US-4186143-A Chenodeoxycholic acid recovery process CANADA PACKERS LIMITED (CA) 1980-01-29 US claimed
US-4185099-A ANTIDANDRUFF AGENTS Also Laboratori S.a.S. di Dr.P. Sorbini & C (IT) 1980-01-22 US claimed
US-4163017-A High purity chenodeoxycholic acid and method for obtaining same DIAMALT AKTIENGESELLSCHAFT (DE) 1979-07-31 US claimed
US-4140796-A ANTIULCER INTERX RESEARCH CORPORATION (US) 1979-02-20 US claimed
US-4120959-A Labile quaternary ammonium salts useful in binding bile acids in warm-blooded animals INTERX RESEARCH CORPORATION (US) 1978-10-17 US claimed
US-4079133-A Safer method for dissolving gallstones combining hyodeoxycholic acid with chenodeoxycholic acids WARREN-TEED LABORATORIES, INC. (US) 1978-03-14 US claimed
US-4046899-A Labile quaternary ammonium salts useful in binding bile acids in warm-blooded animals INTERNX RESEARCH CORPORATION (US) 1977-09-06 US claimed
US-3998859-A Introducing Δ11 unsaturation into steroid compounds EASTMAN KODAK COMPANY (US) 1976-12-21 US claimed
US-3969503-A STEROID INTELLECTUAL PROPERTY DEVELOPMENT CORPORATION (US) 1976-07-13 US claimed
US-3965131-A Process for the purification of crude chenodeoxycholic acid SCHERING AKTIENGESELLSCHAFT (DT) 1976-06-22 US claimed